Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA

Delayed Quote. Delayed  - 02/10 03:59:57 pm
7.84 USD   -1.88%
02/10 VANDA PHARMACEU : reports 4Q loss
02/10 VANDA PHARMACEU : Reports Fourth Quarter 2015 and Full Year 2015 Fin..
02/01 VANDA PHARMACEU : to Participate in the Canaccord Genuity Rare Disea..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/04/2016 02/05/2016 02/08/2016 02/09/2016 02/10/2016 Date
8.81(c) 8.64(c) 8.02(c) 7.99(c) 7.84(c) Last
631 463 553 198 727 708 440 048 586 382 Volume
-0.23% -1.93% -7.18% -0.37% -1.88% Change
More quotes
Financials ($)
Sales 2015 109 M
EBIT 2015 -31,8 M
Net income 2015 -33,9 M
Debt 2015 117 908 M
Yield 2015 -
Sales 2016 148 M
EBIT 2016 -32,1 M
Net income 2016 -30,1 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
Capi. / Sales 2015 1 081x
Capi. / Sales 2016 2,31x
Capitalization 342 M
More Financials
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its product portfolio includes Fanapt and Tasimelteon.The Fanapt product is a compound for the treatment of schizophrenia, the... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on VANDA PHARMACEUTICALS INC.
02/10 VANDA PHARMACEUTICALS : reports 4Q loss
02/10 VANDA PHARMACEUTICALS : Results of Operations and Financial Condition, Financial..
02/10 VANDA PHARMACEUTICALS : Reports Fourth Quarter 2015 and Full Year 2015 Financial..
02/04 VANDA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial St..
02/01 VANDA PHARMACEUTICALS : to Participate in the Canaccord Genuity Rare Disease, Bi..
01/27 VANDA PHARMACEUTICALS : to Announce Fourth Quarter and Full Year 2015 Financial ..
01/22 VANDA PHARMACEUTICALS : to Announce Fourth Quarter and Full Year 2015 Financial ..
01/11 VANDA PHARMACEUTICALS : Results of Operations and Financial Condition, Regulatio..
More news
Sector news : Bio Therapeutic Drugs
12:36a LONZA : Partners with Octane Biotech
02/10 LONZA : and Renova Therapeutics Announce Manufacturing Agreement for Clinical Su..
02/10 PFIZER : Commends The FDA Advisory Committee's Vote To Approve Proposed Biosimil..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
02/10 Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q4 2015 Results - ..
02/10 Vanda Pharmaceuticals (VNDA) Q4 2015 Results - Earnings Call Webcast
02/10 Vanda Pharmaceuticals beats by $0.03, beats on revenue
02/09 Notable earnings after Wednesday?s close
2015 PREMARKET BIOTECH DIGEST : Portola's Milestone, Shkreli Resigns, BioMarin DMD Dr..


Comments 
Advertisement
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Technical analysis trends VANDA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions